Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation - ScienceDirect
The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML | Oncogene
BET bromodomain inhibitor JQ1 preferentially suppresses EBV-positive nasopharyngeal carcinoma cells partially through repressing c-Myc | Cell Death & Disease
BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model
Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway
Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours | British Journal of Cancer
BET inhibition induces an anti-apoptotic adaptive response and therapeutic vulnerability to MCL1 inhibitors in breast cancer | bioRxiv
Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway
BET inhibitors: a novel epigenetic approach - Annals of Oncology
The Killing of Human Neuroblastoma Cells by the Small Molecule JQ1 Occurs in a p53-Dependent Manner | Bentham Science
Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer | Scientific Reports
Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections | PNAS
JQ1 inhibits the proliferation, migration, and invasion of gastric... | Download Scientific Diagram
Bromodomain inhibitors in clinical trials | Download Table
The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitors - eBioMedicine
Repression of BET activity sensitizes homologous recombination–proficient cancers to PARP inhibition | Science Translational Medicine
JQ1 reduces proliferation and survival of glioblastoma stem cells and... | Download Scientific Diagram
Inhibitors of bromodomain and extra‐terminal proteins for treating multiple human diseases - Kulikowski - 2021 - Medicinal Research Reviews - Wiley Online Library
Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway
Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer - ScienceDirect
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression - ScienceDirect
The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice | Translational Psychiatry
Predicting response to BET inhibitors using computational modeling: A BEAT AML project study - ScienceDirect
